CRISPR-Cas9: Advancing Veterinary Science and Revolutionizing Animal Health

Animal diseases are bound to threaten livestock production, animal welfare, and human health. The researchers involve attempts at controlling and restricting the spread of such diseases for safe food production for animal-origin products. Immunogenomics, a combination of transcriptomic and genomic data, shows promise in evaluating and boosting host resistance against diseases. The next-generation sequencing based technology is an advanced system where high throughput of information regarding the genomic and transcriptomic profiles is gained as a system of host-pathogen interaction functioning. Advanced editions in the field of genome editing such as insertion, deletion, or alteration of any genes have opened possibilities commercially that livestock can manage disease in food production. The momentum of CRISPR/Cas9 targeted genome editing as viable target applications in animal breeding against diseases continues to be gathering pace. Immunogenomics is still a mostly unexplored area, but rapidly gaining momentum, and yet the scope in technological advancement with respect to animal agriculture production.